Trials / Completed
CompletedNCT02027025
Study of SPARC1103 in Subjects With Spasticity
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- Sun Pharma Advanced Research Company Limited · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study of SPARC1103 in subjects with spasticity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SPARC1103 low dose | once daily |
| DRUG | SPARC1103 high dose | once daily |
| DRUG | SPARC Placebo |
Timeline
- Start date
- 2014-04-21
- Primary completion
- 2017-04-28
- Completion
- 2017-04-28
- First posted
- 2014-01-03
- Last updated
- 2019-05-03
- Results posted
- 2019-01-15
Locations
23 sites across 3 countries: United States, Russia, Ukraine
Source: ClinicalTrials.gov record NCT02027025. Inclusion in this directory is not an endorsement.